Current Pharmaceutical Design logo Bentham Science Publishers logo

Current Pharmaceutical Design publishes timely in-depth reviews covering all aspects of current research in rational drug design. Each issue is devoted to a single major therapeutic area. A Guest Editor who is an acknowledged authority in a therapeutic field has solicits for each issue comprehensive and timely reviews from leading researchers in the pharmaceutical industry and academia.

Each thematic issue of Current Pharmaceutical Design covers all subject areas of major importance to modern drug design, including: medicinal chemistry, pharmacology, drug targets and disease mechanism.

Publisher: Bentham Science Publishers

Volume 15, Number 22, August 2009
Key:
Free Content - Free Content
New Content - New Content
Subscribed Content - Subscribed Content
Free Trial Content - Free Trial Content

< previous issue | next issue > | all issues

Articles

Editorial [Hot Topic: Perspectives in Psychopharmacological Neuroimaging (Executive Editor: Paolo Fusar-Poli)]
pp. 2533-2534(2)
Author: Poli, Paolo F.u.s.a.r.

Free Content The Effects of Antipsychotics on the Brain: What Have We Learnt from Structural Imaging of Schizophrenia? A Systematic Review
pp. 2535-2549(15)
Authors: Smieskova, R.; Fusar-Poli, P.; Allen, P.; Bendfeldt, K.; Stieglitz, R. D.; Drewe, J.; Radue, E. W.; McGuire, P. K.; Riecher-Rossler, A.; Borgwardt, S. J.

Mechanisms Underlying Psychosis and Antipsychotic Treatment Response in Schizophrenia: Insights from PET and SPECT Imaging
pp. 2550-2559(10)
Authors: Howes, O. D.; Egerton, A.; Allan, V.; McGuire, P.; Stokes, P.; Kapur, S.

Functional Imaging as a Tool to Investigate the Relationship between Genetic Variation and Response to Treatment with Antipsychotics
pp. 2560-2572(13)
Authors: Di Giorgio, A.; Sambataro, F.; Bertolino, A.

What do ERPs and ERFs Reveal About the Effect of Antipsychotic Treatment on Cognition in Schizophrenia?
pp. 2573-2593(21)
Authors: Korostenskaja, M.; Kahkonen, S.

Imaging the Glutamate System in Humans: Relevance to Drug Discovery for Schizophrenia
pp. 2594-2602(9)
Author: Stone, James M.

Imaging the Neural Effects of Cannabinoids: Current Status and Future Opportunities for Psychopharmacology
pp. 2603-2614(12)
Authors: Bhattacharyya, S.; Crippa, J. A.; Martin-Santos, R.; Winton-Brown, T.; Fusar-Poli, P.

Connecting the Brain and New Drug Targets for Schizophrenia
pp. 2615-2631(17)
Authors: Whalley, H. C.; Steele, J. D.; Mukherjee, P.; Romaniuk, L.; McIntosh, A. M.; Hall, J.; Lawrie, S. M.

Myelination in Bipolar Patients and the Effects of Mood Stabilizers on Brain Anatomy
pp. 2632-2636(5)
Authors: Brambilla, Paolo; Bellani, Marcella; Yeh, Ping-Hong; Soares, Jair C.

Neuroimaging and Genetics of Antidepressant Response to Sleep Deprivation: Implications for Drug Development
pp. 2637-2649(13)
Authors: Benedetti, Francesco; Smeraldi, Enrico

< previous issue | next issue > | all issues

Key:
Free Content - Free Content
New Content - New Content
Subscribed Content - Subscribed Content
Free Trial Content - Free Trial Content
Share this item with others: These icons link to social bookmarking sites where readers can share and discover new web pages.
Page Help Click here for Page Help
Shopping cart
Tools
Sign in






Need to register?
Sign up here
Text size: A | A | A | A